Differential presynaptic modulation of noradrenaline release in human atrial tissue in normoxia and anoxia

British Journal of Pharmacology

Volumn 118, Issue 7, 1996, Pages 1855-1861

  Münch, Götz ^a,b   Kurz, Thomas ^a   Urlbauer, Thomas ^a   Seyfarth, Melchior ^a   Richardt, Gert ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Anoxia; Human cardiac tissue; Noradrenaline release; Presynaptic modulation; Presynaptic receptors

Indexed keywords

8 PHENYLTHEOPHYLLINE; ADENOSINE; ADENOSINE RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN II ANTAGONIST; ANGIOTENSIN RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; LOSARTAN; NORADRENALIN; PINDOLOL; TERBUTALINE; YOHIMBINE;

ANOXIA; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; HEART ATRIUM; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; NORADRENALIN RELEASE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; SYMPATHETIC TONE;

EID: 0029980254     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15614.x     Document Type: Article

References (32)

1. BOHMANN, C., SCHOLLMEYER, P. & RUMP, L.C. (1993). Methoxamine inhibits noradrenaline release through activation of alpha 1- and alpha2-adrenoceptors in the rat isolated kidney: involvement of purines and prostaglandins. Naunyn-Schmiedeberg's Arch. Pharmacol., 347, 273-279.
2. BRODDE, O.E. (1988). The functional importance of beta1 and beta2 adrenoceptors in the human heart. Am. J. Cardiol., 62, 24C 29C.
3. BUTTERFIELD, M.C. & CHESS-WILLIAMS, R. (1990). Enhanced alpha-adrenoceptor responsiveness and receptor number during global ischaemia in the Langendorff perfused rat heart. Br. J. Pharmacol., 100, 641-645.
4. CARR, E.A., CAROLL, M., COUNSELL, R.E. & TYSON, J.W. (1979). Studies of uptake of the bretylium analogue, iodobenzyltri-methylammonium iodide, by non-primate, monkey and human hearts. Br. J. Clin. Pharmacol., 8, 425-432.
5. CATERALL, W.A., NUONOKI, K., LAI, V., DEJONGH, K., THOMSEN, W. & ROSSIE, S. (1990). Structure and modulation of voltage-sensitive sodium and calcium channels. Adv. Second Messenger Phosphoprotein Res., 24, 30-35.
6. CORR, P.B. & GILLIS, R.A. (1978). Autonomic neural influences on the dysrhythmias resulting from myocardial infarction. Circ. Res.,43, 1-9.
7. DART, A.M., SCHÖMIG, A., DIETZ, R., MAYER, E. & KÜBLER, W. (1984). Release of endogenous catecholamines in the ischemic myocardium of the rat. Part B: Effect of sympathetic nerve stimulation. Circ. Res., 55, 702-706.
8. DU. X.-J., DART, A.M., RIEMERSMA, R.A. & OLIVER, M.F. (1990). Failure of the cholinergic modulation of norepinephrine release during acute myocardial ischemia in the rat. Circ. Res., 66, 950 956.
9. ESLER, M., JACKMAN, G., LEONARD, P., SKRWS, H., BOBIK, A. & KORNER, P. (1981). Effect of norepinephrine uptake blockers on norepinephrine kinetics. Clin. Pharmacol. Ther., 29, 12-20.
10. ITOH, A., MIWA, S., KOSHIMURA, K., AKIYAMA, Y., TAKAGI, Y., YAMAGATA, S., KIKUCHI, H. & MASAKI, T. (1994). Ischemia-induced changes in catecholamine release and their mechanisms: a study using cultured bovine adrenal chromaffin cells. Brain Res., 643, 266-275.
11. MATKO, I., FEHER, E. & VIZI, E.S. (1994). Receptor mediated presynaptic modulation of the release of noradrenaline in human papillary muscle. Cardiovasc. Res., 28, 700-704.
12. MUKHERJEE, A., WONG, T.M., BUJA, L.M., LEFKOWITZ, R.J. & WILLERSON, J.T. (1979). Beta adrenergic and muscarinic cholinergic receptors in canine myocardium. J. Clin. Invest., 64, 1423-1428.
13. NIROOMAND, F., BANGERT, M., BEYER, T. & RAUCH, B. (1992). Reduced adenylyl cyclase inhibition by carbachol and GTP during acute myocardial ischaemia. J. Mol. Cell. Cardiol., 24, 471-475.
14. NIROOMAND, L., WEINBRENNER, C., WEIS, A., BANGERT, M., SCHWENKE, C., MARQUETANT, T., BEYLR, T., STRASSER, R.H., KÜBLER, W. & RAUCH, H. (1995). Impaired function of inhibitory G proteins during acute myocardial ischemia of canine hearts and its reversal during reperfusion and a second period of ischemia. Possible implications of ischemic preconditioning. Circ. Res., 76, 861-870.
15. NODA, K., SASAURI, M., IDEISHI, M., IKEDA, M. & ARAKAWA, K. (1993). Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovasc. Res., 27, 334-340.
16. ORDWAY, G.A., JACONETTA, S.M. & HALARIS, A.E. (1993). Characterization of subtypes of alpha-2 adrenoceptors in the human brain. J. Pharmacol. Exp. Ther., 264, 967-976.
17. PFEFFER, M.A., LAMAS, G.A., GERVASIO, A.L., VAUGHAN, D.E., PARISI, A.F. & BRAUNWALD, E. (1988). Effect of captopril on progressive ventricular dilation after anterior myocardial infarction. N. Engl. J. Med., 319, 80-86.
18. REGITZ-ZAGROSEK, V., FRIEDEL, N., HEYMANN, A., BAUER, P., NEUB, M., ROLFS, A., STEFFEN, C., HILDEBRANDT, A., HETZER, R. & FLECK, E. (1995). Regulation, chamber localisation, and subtype distribution of angiotensin II receptors in human hearts. Circulation, 91, 1461-1471.
19. RICHARDT, G., WASS, W., KRANZHÖFER, R., MAYER, E. & SCHÖMIG, A. (1987). Adenosine inhibits exocytotic release of endogenous noradrenaline in the rat heart: a protective mechanism in early myocardial ischemia. Circ. Res., 61, 117-123.
20. RONA, G. (1985). Catecholamine cardiotoxicity. J. Mol. Cell. Cardiol., 17, 291-306.
21. RUMP, L.C., SCHWERTFEGER, E., SCHAIBLE, U., FRAEDRICH, G. & SCHOLLMEYER, P. (1994). Beta 2-adrenergic receptor and angiotensin II receptor modulation of sympathetic neurotransmission in human atria. Circ. Res., 74, 434-440.
22. SCHRADER, J. & GERLACH, E. (1976). Compartmentation of cardiac adenine nucleotides and formation of adenosine. Pflüg. Arch., 367, 129-135.
23. SCHÖMIG, A. (1990). Catecholamines in myocardial ischemia. Systemic and cardiac release. Circulation, 82 (suppl II), II-13-II-22.
24. SCHÖMIG, A., FISCHER, S., KURZ, T., RICHARDT, G. & SCHÖMIG, E. (1987). Nonexocytotic release of endogenous noradrenaline in the ischémic and anoxic rat heart: mechanisms and metabolic requirements. Circ. Res., 60, 194-205.
25. SCHÖMIG, A., RICHARDT, G. & KURZ, T. (1995). Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact. Herz, 20, 169-186.
26. SEYFARTH, M., FENG, Y., HAGL, F., SEBENING, F., RICHARDT, G. & SCHÖMIG, A. (1993). Effect of myocardial ischemia on stimulation-evoked noradrenaline release. Modulated neurotransmission in rat, guinea pig, and human atrial tissue. Circ. Res., 73, 496-502.
27. STJÄRNE, L., BAO, J.X., GONON, F., MSGHINA, M. & STJÄRNE, E. (1992). On the geometry, kinetics and plasticity of sympathetic neuromuscular transmission. Jpn. J. Pharmacol., 58 [suppl II], 158p-165p.
28. STRASSER, R.H., BRAUN-DULLAEUS, R., WALENDZIK, H. & MARQUETANT, R. (1992). Alpha-1-receptor-independent activation of protein kinase C in acute myocardial ischema. Mechanisms for sensitization of adenylyl cyclase system. Circ. Res., 70, 1304-1312.
29. STRASSER, R.H. & MARQUETANT, R. (1990). Supersensitivity of adenylyl cyclase system in acute myocardial ischemia: evaluation of three independent mechanisms. Basic. Res. Cardiol., 85 suppl. 1, 67-78.
30. SUSANNI, E.E., MANDERS, W.T., KNIGHT, D.R., VATNER, D.E., VATNER, S.F. & HOMCY, C.J. (1989). One hour of myocardial ischemia decreases the activity of the stimulatory guanine-nucleotide regulatory proteins Gs. Circ. Res., 65, 1145-1150.
31. TRENDELENBURG, U., STEFANO, F.J.E. & GROHMANN, M. (1983). The isotope effect of tritium in 3-H-noradrenaline. Naunyn-Schiedeberg's Arch. Pharmacol., 323, 128-140.
32. TRENDELENBURG, U., SCHÖNFELD, C.L. & SCHÖMIG, E. (1990). The efficiency of the neuronal re-uptake of noradrenaline and the inhomogeniety of labelling of an incubated tissue inhomogeneity. Neurochem. Int., 17, 139-147.